Cyprus/Greece/MaltaCyprusGreeceMalta

New biotech laws for Malta

12.08.2005

La Valetta - After a broad discussion process Malta's Social Affairs Committee has presented a draft regulation on biotechnology and assisted reproduction to the parliament in July.
According to the proposals the fertilised ovum will be given the status of an embryo with full human rights. Consequently, creation of embryos for research purposes and cloning will be prohibited. But cells extracted from the umbilical cord blood, placenta, as well as adult stem cells could be used for research, while cells from a natural miscarriage are accessible only with the permission of the parents.
Genetic diagnosis should be allowed on condition that it is used for medical and forensic reasons only, or to correct specific abnormalities in the embryo. Pre-implantation diagnosis will be prohibited, pre-natal testing should be allowed if there is a possibility of the parents passing on a genetic disease to their children.
Assisted procreation should be allowed under certain conditions: third party donors and surrogate motherhood should not be allowed. In cases where the parents are not able to use the embryos - due to the mother's death, for example - these embryos can be put up for adoption according to Maltese law.
Nationalist MP Clyde Puli - Chairman of the Committee - pointed out that after seven months of discussion, the time has come to take a decision. Concerning the protest of members of opposition he added that once the law was implemented, changes could be made through a legal notice.
However, the Committee's recomendations have been met with mixed reactions in professional circles. While many medical professionals agree that it is important to include a clear legal definition of the beginning of human life, most doctors seem to see the definition put forward by the Committee as, at best, “a conservative compromise.” Especially gynaecologists have expressed their concern that the Committee's definition might “hinder the process of IVF”.

Cyprus/Greece/MaltaCyprusGreeceMalta

29.01.2006

Crete - Using an implanted device to make the heart beat faster in pacemaker patients with obstructive sleep apnea-hypopnea syndrome does not help, according to a study of Greek researchers. The physicians around Professor Panos...

Cyprus/Greece/MaltaCyprusGreeceMalta

26.11.2005

Nicosia - A rare medical condition has been found to be nine times more prevalent in Cypriots living in Paphos than in the rest of Cyprus or the European Union. Results of research carried out by the Neurology and Genetic...

Cyprus/Greece/MaltaCyprusGreeceMalta

26.11.2005

Brussels - The European Union's Agricultural Council has failed to reach a qualified majority for rejecting or upholding the Greek ban on genetically modified (GM) maize Mon 810. EuropaBio, the organization representing Europe's...

Cyprus/Greece/MaltaCyprusGreeceMalta

28.09.2005

Nicosia - US-based Genaissance Pharmaceuticals Inc. announced in September that it will provide its high-throughput genotyping services to Cyprus' Biotronics Ltd. Biotronics has been awarded a contract by the Veterinary Services...

Cyprus/Greece/MaltaCyprusGreeceMalta

12.08.2005

Athens - The Greek government announced in August a collaborative agreement between its contractor Antisel A. Selidis and US-based Genaissance Pharmaceuticals in the field of scrapie genotyping.Under the terms of the agreement,...

Cyprus/Greece/MaltaCyprusGreeceMalta

10.07.2005

La Valletta - Synergene Biotechnology Group, a Malta-based biotech company, in line with its expansion programme has recently appointed several new members to the board of directors of Synergene Technologies Limited. The new...

Cyprus/Greece/MaltaCyprusGreeceMalta

10.07.2005

Valletta - In mid-June the Social Affairs Committee of the House of Representatives has ended its consultation process regarding the use of biotechnology in Malta. The Committee is currently discussing a report compiled by the...

Cyprus/Greece/MaltaCyprusGreeceMalta

10.05.2005

Athens - Greece supports the development of biotechnology but is wary of its side effects, Greek Development Minister Dimitris Sioufas said during the first national Greek biotechnology and food technology conference held on...

Cyprus/Greece/MaltaCyprusGreeceMalta

10.05.2005

Athens/Lugano - Helsinn Healthcare S.A., a Swiss pharmaceutical group, and Galenica, a Greek pharmaceutical company, announced recently the signing of an agreement granting Galenica the exclusive licence and distribution rights...

Cyprus/Greece/MaltaCyprusGreeceMalta

10.05.2005

Nicosia - Delivering the promise of nanotechnology to society for much-awaited products and jobs, hinges critically on transferring manufacturing technology to industrial production. For this purpose, the University of Cyprus...

Displaying results 21 to 30 out of 47

< Previous 21-30 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-cyprus-greece-malta/browse/2/article/new-biotech-laws-for-malta.html

Events

All Events

Stock list

All quotes

TOP

  • 4SC1.23 EUR6.03%
  • VITA 343.96 EUR4.49%
  • WILEX2.36 EUR4.42%

FLOP

  • CYTOS0.26 CHF-3.70%
  • MOLOGEN7.10 EUR-2.74%
  • ADDEX4.00 CHF-1.72%

TOP

  • SANTHERA82.95 CHF19.7%
  • MAGFORCE6.50 EUR10.2%
  • LONZA101.10 CHF7.1%

FLOP

  • MOLOGEN7.10 EUR-24.5%
  • WILEX2.36 EUR-24.4%
  • 4SC1.23 EUR-15.2%

TOP

  • SANTHERA82.95 CHF3850.0%
  • CO.DON2.50 EUR228.9%
  • PAION2.48 EUR198.8%

FLOP

  • CYTOS0.26 CHF-93.5%
  • MEDIGENE4.65 EUR-67.7%
  • MERCK KGAA64.40 EUR-45.7%

No liability assumed, Date: 21.08.2014


Current issue

All issues

Product of the week

Products